Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: A multimodal analysis

Neuroscience

Volumn 144, Issue 4, 2007, Pages 1293-1304

  Leonelli, E ^a   Bianchi, R ^b   Cavaletti, G ^c   Caruso, D ^a   Crippa, D ^d   Garcia Segura, L M ^e   Lauria, G ^f   Magnaghi, V ^a   Roglio, I ^a   Melcangi, R C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d Schering SpA   (Italy)

^e INSTITUTO CAJAL   (Spain)

^f DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

diabetes; myelin; neuroactive steroids; rat; sciatic nerve; streptozotocin

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); GLYCOPROTEIN; GLYCOPROTEIN ZERO; LIGAND; MESSENGER RNA; MYELIN PROTEIN; NEUROPROTECTIVE AGENT; PROGESTERONE; PROGESTERONE DERIVATIVE; PROGESTERONE RECEPTOR; PROTEIN 22; SESAME SEED OIL; STEROID; STREPTOZOCIN; TETRAHYDROPROGESTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG MECHANISM; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HEAT SENSITIVITY; MALE; MASS SPECTROMETRY; MEDICAL RESEARCH; NERVE CONDUCTION; NERVE DEGENERATION; NERVE FIBER; NEUROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SKIN NERVE; STREPTOZOCIN DIABETES;

20-ALPHA-DIHYDROPROGESTERONE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOWN-REGULATION; MALE; MYELIN PROTEINS; NA(+)-K(+)-EXCHANGING ATPASE; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; PAIN THRESHOLD; PERIPHERAL NERVES; PREGNANOLONE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, SENSORY; RECOVERY OF FUNCTION; RNA, MESSENGER; SKIN; TREATMENT OUTCOME;

EID: 33846287960     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.11.014     Document Type: Article

References (70)

1. Andreis P.G., Mazzocchi G., Cavallini L., Rebuffat P., and Nussdorfer G.G. Morphology and functional responses of isolated zona glomerulosa cells of streptozotocin-induced diabetic rats. Exp Pathol 39 (1990) 65-71
2. Azcoitia I., Leonelli E., Magnaghi V., Veiga S., Garcia-Segura L.M., and Melcangi R.C. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol Aging 24 (2003) 853-860
3. Babichev V.N., Adamskaya E.I., Kuznetsova T.A., and Shishkina I.V. Neuroendocrine control of the gonadotropic function of the hypophysis in experimental diabetes. Neurosci Behav Physiol 28 (1998) 1-7
4. Berry E.M. Dietary fatty acids in the management of diabetes mellitus. Am J Clin Nutr 66 (1997) 991S-997S
5. Bianchi R., Marini P., Merlini S., Fabris M., Triban C., Mussini E., and Fiori M.G. ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment. Diabetes 37 (1988) 1340-1345
6. Bianchi R., Buyukakilli B., Brines M., Savino C., Cavaletti G., Oggioni N., Lauria G., Borgna M., Lombardi R., Cimen B., Comelekoglu U., Kanik A., Tataroglu C., Cerami A., and Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A 101 (2004) 823-828
7. Biessels G.-J., Cristino N.A., Rutten G.-J., Hamers F.P.T., Erkelens D.W., and Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Brain 122 (1999) 757-768
8. Branisteanu D.D., and Mathieu C. Progesterone in gestational diabetes mellitus: guilty or not guilty?. Trends Endocrinol Metab 14 (2003) 54-56
9. Bronstein J.M. Function of tetraspan proteins in the myelin sheath. Curr Opin Neurobiol 10 (2000) 552-557
10. Calcutt N.A., Freshwater J.D., and O'Brien J.S. Protection of sensory and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats. Anesthesiology 93 (2000) 1271-1278
11. Cameron N.E., and Cotter M.A. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabet Metab Rev 10 (1994) 189-224
12. Castellano J.M., Navarro V.M., Fernandez-Fernandez R., Roa J., Vigo E., Pineda R., Dieguez C., Aguilar E., Pinilla L., and Tena-Sempere M. Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats. Diabetes 55 (2006) 2602-2610
13. Chan O., Chan S., Inouye K., Vranic M., and Matthews S.G. Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effects of insulin treatment. Endocrinology 142 (2001) 4872-4879
14. Chan O., Chan S., Inouye K., Shum K., Matthews S.G., and Vranic M. Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses. Diabetes 51 (2002) 1681-1689
15. Chan O., Inouye K., Akirav E., Park E., Riddell M.C., Vranic M., and Matthews S. Insulin alone increases hypothamo-pituitary-adrenal activity, and diabetes lowers peak stress responses. Endocrinology 146 (2005) 1382-1390
16. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
17. Christianson J.A., Riekhof J.T., and Wright D.E. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol 179 (2003) 188-199
18. Dawson-Basoa M., and Gintzler A.R. Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Res 757 (1997) 37-42
19. Dawson-Basoa M., and Gintzler A.R. Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems. Brain Res 794 (1998) 61-67
20. Désarnaud F., Do Thi A.N., Brown A.M., Lemke G., Suter U., Baulieu E.E., and Schumacher M. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem 71 (1998) 1765-1768
21. Doss D.J., Kuruvilla R., Bianchi R., Peterson R.G., and Eichberg J. Effects of hypoxia and severity of diabetes on Na,K-ATPase activity and arachidonoyl-containing glycerophospholipid molecular species in nerve from streptozotocin diabetic rats. J Peripher Nerv Syst 2 (1997) 155-163
22. Durant S., Christeff N., Coulaud J., Nunez E.A., Dardenne M., and Homo-Delarche F. Basal concentrations of various steroids in the nonobese diabetic (NOD) mouse and effect of immobilization stress. Autoimmunity 28 (1998) 249-258
23. Dyck P.J., Zimmerman B.R., Vilen T.H., Minnerath S.R., Karnes J.L., Yao J.K., and Poduslo J.F. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 319 (1988) 542-548
24. Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol 50 (2002) 293-321
25. El'tseva T.V., Adamskaya E.I., Peryshkova T.A., and Babichev V.N. Disturbance of neuroendocrine regulation of sexual behavior of male rats with streptozotocin diabetes. Neurosci Behav Physiol 23 (1993) 538-544
26. Garcia-Ovejero D., Azcoitia I., DonCarlos L.L., Melcangi R.C., and Garcia-Segura L.M. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res Rev 48 (2005) 273-286
27. Garcia-Segura L.M., Veiga S., Sierra A., Melcangi R.C., and Azcoitia I. Aromatase: a neuroprotective enzyme. Prog Neurobiol 71 (2003) 31-41
28. Garris D.R. Gonadal steroid modulation of the diabetes (db/db) mutation-induced hyperlipometabolic, hypogonadal syndrome: restoration of female reproductive tract cytochemical and structural indices. Pathophysiology 12 (2005) 109-120
29. Gonzalez Deniselle M.C., Lopez-Costa J.J., Saavedra J.P., Pietranera L., Gonzalez S.L., Garay L., Guennoun R., Schumacher M., and De Nicola A.F. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol Dis 11 (2002) 457-468
30. Greene D.A., Lattimer-Greene S., and Sima A.A. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Crit Rev Neurobiol 5 (1989) 143-219
31. Griffin L.D., Gong W., Verot L., and Mellon S.H. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 10 (2004) 704-711
32. Hassan A.A., Hassouna M.M., Taketo T., Gagnon C., and Elhilali M.M. The effects of diabetes on sexual behavior and reproductive tract function in male rats. J Urol 149 (1993) 148-154
33. Koenig H.L., Schumacher M., Ferzaz B., Do Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., and Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 268 (1995) 1500-1503
34. Labombarda F., Gonzalez S.L., Gonzalez D.M., Guennoun R., Schumacher M., and de Nicola A.F. Cellular basis for progesterone neuroprotection in the injured spinal cord. J Neurotrauma 19 (2002) 343-355
35. A receptors. Prog Neurobiol 71 (2003) 67-80
36. Lauria G., Morbin M., Lombardi R., Borgna M., Mazzoleni G., Sghirlanzoni A., and Pareyson D. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 61 (2003) 631-636
37. Lauria G., Lombardi R., Borgna M., Penza P., Bianchi R., Savino C., Canta A., Nicolini G., Marmiroli P., and Cavaletti G. Intraepidermal nerve fiber density in rat foodpad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 10 (2005) 199-205
38. Leonelli E., Yague J.G., Ballabio M., Azcoitia I., Magnaghi V., Schumacher M., Garcia-Segura L.M., and Melcangi R.C. Ro5-4864, a synthetic ligand of peripheral benzodiazepine receptor, reduces aging-associated myelin degeneration in the sciatic nerve of male rats. Mech Ageing Dev 126 (2005) 1159-1163
39. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
40. Magnaghi V., Cavarretta I., Galbiati M., Martini L., and Melcangi R.C. Neuroactive steroids and peripheral myelin proteins. Brain Res Rev 37 (2001) 360-371
41. Magnaghi V., Veiga S., Ballabio M., Gonzalez L.C., Garcia-Segura L.M., and Melcangi R.C. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells. J Peripher Nerv Syst 11 (2006) 112-119
42. Margolis K.L., Bonds D.E., Rodabough R.J., Tinker L., Phillips L.S., Allen C., Bassford T., Burke G., Torrens J., Howard B.V., and Women's Health Initiative Investigators. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47 (2004) 1175-1187
43. Melcangi R.C., Magnaghi V., Cavarretta I., Martini L., and Piva F. Age-induced decrease of glycoprotein P0 and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience 85 (1998) 569-578
44. Melcangi R.C., Magnaghi V., Cavarretta I., Zucchi I., Bovolin P., D'Urso D., and Martini L. Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J Neurosci Res 56 (1999) 349-357
45. Melcangi R.C., Magnaghi V., Galbiati M., Ghelarducci B., Sebastiani L., and Martini L. The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin?. J Neurocytol 29 (2000) 327-339
46. Melcangi R.C., Magnaghi V., Galbiati M., and Martini L. Formation and effects of neuroactive steroids in the central and peripheral nervous system. Int Rev Neurobiol 46 (2001) 145-176
47. Melcangi R.C., Leonelli E., Magnaghi V., Gherardi G., Nobbio L., and Schenone A. Mifepristone (RU 38486) influences expression of glycoprotein P0 and morphological parameters at the level of rat sciatic nerve: in vivo observations. Exp Neurol 184 (2003) 930-938
48. Patte-Mensah C., Li S., and Mensah-Nyagan A.G. Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain cleavage in sensory neural networks. Cell Mol Life Sci 61 (2004) 2274-2284
49. Periquet M.I., Novak V., Collins M.P., Nagaraja H.N., Erdem S., Nash S.M., Freimer M.L., Sahenk Z., Kissel J.T., and Mendell J.R. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 53 (1999) 1641-1647
50. Picard F., Watanabe M., Schoonjans K., Lydon J., O'Malley B.W., and Auwerx J. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to β-cell proliferation. Proc Natl Acad Sci U S A 99 (2002) 15644-15648
51. Rebuffat P., Malendowicz L.K., Mazzocchi G., Gottardo G., and Nussdorfer G.G. Streptozotocin-induced experimental diabetes causes a time-dependent inhibition of growth and steroidogenic capacity of rat adrenal zona glomerulosa. Res Exp Med (Berl) 190 (1990) 1-12
52. Salonia A., Lanzi R., Scavini M., Pontillo M., Gatti E., Petrella G., Licata G., Nappi R.E., Bosi E., Briganti A., Rigatti P., and Montorsi F. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 29 (2006) 312-316
53. Saredi S., Patte-Mensah C., Melcangi R.C., and Mensah-Nyagan A.G. Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3beta-hydroxysteroid dehydrogenase in the rat spinal cord. Neuroscience 135 (2005) 869-877
54. +-ATPase activity in the pathogenesis of diabetic neuropathy. J Neurol Sci 120 (1993) 159-167
55. Schumacher M., Weill-Engerer S., Liere P., Robert F., Franklin R.J.M., Garcia-Segura L.M., Lambert J.J., Mayo W., Melcangi R.C., Parducz A., Suter U., Carelli C., Baulieu E.E., and Akwa Y. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71 (2003) 3-29
56. Sereda M.W., Meyer zu Horste G., Suter U., Uzma N., and Nave K.-A. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Neurosci 9 (2003) 1533-1537
57. Sudha S., Valli G., Julie P.M., Arunakaran J., Govindarajulu P., and Balasubramanian K. Influence of streptozotocin-induced diabetes and insulin treatment on the pituitary-testicular axis during sexual maturation in rats. Exp Clin Endocrinol Diabetes 108 (2000) 14-20
58. Sugimoto K., Murakawa Y., and Sima A.A.F. Diabetic neuropathy: a continuing enigma. Diabetes Metab Res Rev 16 (2000) 408-433
59. Suter U., and Scherer S.S. Disease mechanisms in inherited neurophathies. Nat Rev Neurosci 4 (2003) 714-726
60. Tanaka M., Nakaya S., Kumai T., Watanabe M., Matsumoto N., and Kobayashi S. Impaired testicular function in rats with diet-induced hypercholesterolemia and/or streptozotocin-induced diabetes mellitus. Endocr Res 27 (2001) 109-117
61. Tesfaye S., Chaturvedi N., Eaton S.E.M., Ward J.D., Manes C., Ionescu-Tirgoviste C., Witte D.R., and Fuller J.H. Vascular risk factors and diabetic neuropathy. N Engl J Med 352 (2005) 341-350
62. Tredici G., Tredici S., Fabbrica D., Minoia C., and Cavaletti G. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J Neurooncol 36 (1998) 31-40
63. Underwood R.A., Gibran N.S., Muffley L.A., Usui M.L., and Olerud J.E. Color subtractive-computer-assisted image analysis for quantification of cutaneous nerves in a diabetic mouse model. J Histochem Cytochem 49 (2001) 1285-1291
64. Vallée M., Rivera J.D., Koob G.F., Purdy R.H., and Fitzgerald R.L. Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal Biochem 287 (2000) 153-166
65. van Dam E.W., Dekker J.M., Lentjes E.G., Romijn F.P., Smulders Y.M., Post W.J., Romijn J.A., and Krans H.M. Steroids in adult men with type 1 diabetes: a tendency to hypogonadism. Diabetes Care 26 (2003) 1812-1818
66. Veiga S., Leonelli E., Beelke M., Garcia-Segura L.M., and Melcangi R.C. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci Lett 402 (2006) 150-153
67. Vincent A.M., Russell J.W., Low P., and Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25 (2004) 612-628
68. Vinik A.I., Park T.S., Stansberry K.B., and Pittenger G.L. Diabetic neuropathies. Diabetologia 43 (2000) 957-973
69. Yagihashi S. Nerve structural defects in diabetic neuropathy: do animals exhibit similar changes?. Neurosci Res Commun 21 (1997) 25-32
70. Yorek M.A., Coppey L.J., Gellett J.S., Davidson E.P., Bing X., Lund D.D., and Dillon J.S. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol Endocrinol Metab 283 (2002) E1067-E1075